ObRb downregulation increases breast cancer cell sensitivity to tamoxifen
ObRb downregulation increases breast cancer cell sensitivity to tamoxifen
About this item
Full title
Author / Creator
Publisher
Dordrecht: Springer Netherlands
Journal title
Language
English
Formats
Publication information
Publisher
Dordrecht: Springer Netherlands
Subjects
More information
Scope and Contents
Contents
Leptin is a potent adipokine that plays an important role in the progression of breast cancer and interferes with the action of tamoxifen. We investigated the molecular mechanism underlying the effect of leptin on tamoxifen resistance in breast cancer cells that express leptin receptor (ObRb), and evaluated the impact of ObRb suppression on tamoxif...
Alternative Titles
Full title
ObRb downregulation increases breast cancer cell sensitivity to tamoxifen
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1774963470
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1774963470
Other Identifiers
ISSN
1010-4283
E-ISSN
1423-0380
DOI
10.1007/s13277-015-3375-5
